Stefanie Ueda, MD

Associate Professor
Ob/Gyn, Reproductive Sciences
+1 415 885-7561

Dr. Stefanie M. Ueda is an associate professor in the Department of Obstetrics, Gynecology, and Reproductive sciences in the UCSF School of Medicine. She specializes in gynecologic cancers, with a particular interest in ovarian cancer and robotic surgery. Her research has addressed conditions and treatments including low grade serous and clear cell ovarian cancer, uterine serous cancer, biologically targeted therapies and clinical treatment outcomes. She is part of an ongoing collaborative clinical education and surgical training program with Makarere University and Mulago Hospital in Kampala, Uganda that aims to improve the treatment and management of women gynecological malignancies by training a critical mass of specialists in Uganda.

Publications: 

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN

Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J

Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery.

Obstetrics and gynecology

Chapman JS, Roddy E, Ueda S, Brooks R, Chen LL, Chen LM

Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.

Journal of the National Comprehensive Cancer Network : JNCCN

Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS

Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications.

Gynecologic oncology

Chapman JS, Roddy E, Westhoff G, Simons E, Brooks R, Ueda S, Chen L

Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.

Gynecologic oncology

Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK

Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.

American journal of obstetrics and gynecology

Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK

Foreign- vs US-born Asians and the association of type I uterine cancer.

American journal of obstetrics and gynecology

Simons E, Blansit K, Tsuei T, Brooks R, Ueda S, Kapp DS, Chan JK

Survival in women with grade 1 serous ovarian carcinoma.

Obstetrics and gynecology

Fader AN, Java J, Ueda S, Bristow RE, Armstrong DK, Bookman MA, Gershenson DM

Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer.

Journal of surgical oncology

Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK

Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting.

Gynecologic oncology

Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK

Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE

Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?

Acta cytologica

Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Fader AN

Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas.

Journal of oncology

Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM

Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93.

The American journal of pathology

Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih IeM

Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature.

Women's health (London, England)

Barlin JN, Ueda SM, Bristow RE

Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.

Gynecologic oncology

Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL, Maggioni A

Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

American journal of obstetrics and gynecology

Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK